4D Molecular Therapeutics (FDMT) Price to Sales (2020 - 2026)
4D Molecular Therapeutics' Price to Sales was 10.16 in Q2 2026, down 99.8% from 5250.24 a year earlier but up 41.5% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Price to Sales (2020 - 2026) Analysis & Trends
For FY2025, Price to Sales at 4D Molecular Therapeutics came in at 5.07, down 99.9% from FY2024.
- In earlier years, Price to Sales was 6893.84 in FY2024, 42.11 in FY2023 (-81.8%), 231.59 in FY2022 (+490.9%) and 39.20 in FY2021 (+100.2%).
- Quarterly Price to Sales has moved between 5.07 (Q4 2025) and 33063.75 (Q3 2024) over five years.
- Compared with a year earlier, Price to Sales has declined for four straight quarters, with an average decline of 97.3% over the last four quarters.
- The best year-over-year quarter for Price to Sales over five years was Q1 2023 (growth of 815.8%); the worst was Q4 2025 (a decline of 99.9%).
- Per Business Quant data, FDMT's Price to Sales in the three quarters before Q2 2026 was 7.18 (Q1 2026), 5.07 (Q4 2025) and 3387.01 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | 4D Molecular Therapeutics | 1.01 Bn | -454.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.16 |
| Mar 31, 2026 | 7.18 |
| Dec 31, 2025 | 5.07 |
| Sep 30, 2025 | 3,387.01 |
| Jun 30, 2025 | 5,250.24 |
| Mar 31, 2025 | 6,505.59 |
| Dec 31, 2024 | 6,893.84 |
| Sep 30, 2024 | 33,063.75 |
| Jun 30, 2024 | 53.90 |
| Mar 31, 2024 | 79.69 |
| Dec 31, 2023 | 42.11 |
| Sep 30, 2023 | 24.75 |
| Jun 30, 2023 | 332.42 |
| Mar 31, 2023 | 258.88 |
| Dec 31, 2022 | 231.66 |
| Sep 30, 2022 | 132.00 |
| Jun 30, 2022 | 79.60 |
| Mar 31, 2022 | 28.27 |
| Dec 31, 2021 | 39.20 |
| Sep 30, 2021 | 43.18 |
API Access
4D Molecular Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();